Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|25|8|889-907

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.8, 2018-03, pp. : 889-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Products on Nonalcoholic Fatty Liver Disease

By  

Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. : 1347-1355

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease

By  

Current Pharmaceutical Design, Vol. 23, Iss. 34, 2018-01 ,pp. : 5136-5162

Bentham Science Publishers

Access to resources Recommend Favorite

Methodologies for Investigating Natural Medicines for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 2, 2012-02 ,pp. : 278-291

Bentham Science Publishers

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease: a review

By Poordad F Fred  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Alterations in Hepatic Lipid Metabolism, and their Relation to Dietary Macronutrients in Pediatric Nonalcoholic Fatty Liver Disease

By  

Drug Metabolism Letters, Vol. 9, Iss. 2, 2015-08 ,pp. : 72-79

Bentham Science Publishers

Access to resources Recommend Favorite